# Cardiometabolic Risk Effects of Short-term Cessation of Neurostimulation Therapy

> **NCT06720545** · NA · RECRUITING · sponsor: **Columbia University** · enrollment: 60 (estimated)

## Conditions studied

- Obstructive Sleep Apnea
- Obstructive Sleep Apnea of Adult

## Interventions

- **DEVICE:** No HGNS therapy (HGNS-off)

## Key facts

- **NCT ID:** NCT06720545
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-05
- **Primary completion:** 2027-01
- **Final completion:** 2028-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-07-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06720545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06720545, "Cardiometabolic Risk Effects of Short-term Cessation of Neurostimulation Therapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06720545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*